Try our Advanced Search for more refined results
In Re: Aredia and Zometa Products Liability Litigation
Case Number:
3:06-md-01760
Court:
Nature of Suit:
Multi Party Litigation:
Multi-district Litigation
Judge:
Firms
- Allen & Newman
- Alston & Bird
- Anapol Weiss
- Baker Botts
- Beins Goldberg
- Bertram & Graf
- Bowles & Verna
- Brown & Crouppen
- Bryan Cave
- Burch Porter
- Carlton Fields
- CR Legal Team
- Day Ketterer
- Faegre Drinker
- Farella Braun
- G. Eric Nielson & Associates
- Girardi & Keese
- Goldberg Segalla
- Gould Cooksey
- Halloran & Sage
- Holland & Hart
- Hollingsworth LLP
- Humphrey Farrington
- Kemp Smith
- Law Offices of Sean M. Cleary
- Levin Papantonio
- Lewis & Roberts PLLC
- Lewis Saul & Associates
- Lockridge Grindal
- Maynard Nexsen
- McAfee & Taft
- McDowell Knight
- Morrison Foerster
- Nelson Mullins
- Newsome Melton
- Osborn Law PC
- Reed Smith
- Schroeter Goldmark
- Seeger Weiss
- Sills Cummis
- Sullivan Papain
- Teague Rotenstreich
- Terrell Hogan
- Thornton Law Firm LLP
- Venable LLP
- Watkins & Eager
- Zimmerman Reed
-
March 15, 2013
MDL Judge Limits Medical Fee Claims In 46 Novartis Suits
A Tennessee magistrate judge on Thursday barred plaintiffs from bringing medical expense claims in 46 cases that are part of multidistrict litigation against Novartis Pharmaceutical Corp. over injuries allegedly caused by bone drugs Aredia and Zometa, saying they'd failed to comply with discovery requests.
-
August 03, 2012
Aredia, Zometa MDL Judge Moves To Speed Up Cases
A Tennessee magistrate judge kicked off a discovery overhaul Friday in multidistrict litigation against Novartis Pharmaceutical Corp. over injuries allegedly caused by bone drugs Aredia and Zometa, days after the court revamped a bellwether system to speed up the litigation.
-
October 20, 2011
Novartis Stuck With Sanctions In Bone Drug MDL
A federal judge on Monday levied roughly $55,000 in sanctions against Novartis Pharmaceuticals Corp. in a multidistrict litigation over allegedly concealed health risks associated with two bone cancer drugs, while saying the plaintiffs' requested attorneys' fees were needlessly high.
-
May 20, 2011
Novartis Seeks To Nix Expert Testimony In Bone Drug MDL
Novartis Pharmaceuticals Corp. asked a Tennessee federal judge on Thursday to exclude six experts' testimony in 30 suits in a multidistrict litigation over the bone cancer drugs Aredia and Zometa, the same day it sought to dismiss four of those cases.
-
December 08, 2010
6 Cases Move Forward In Novartis MDL Over Bone Drugs
A federal judge has tossed two suits and nixed strict liability and negligence claims from six other cases in multidistrict litigation accusing Novartis Pharmaceuticals Corp. of failing to warn patients that bone cancer drugs Aredia and Zometa could cause their jawbones to deteriorate.